Partners, CHS align for IT-delivered specialty care

CHS Health Services (CHS), a workforce health management company, has created a strategic partnership with Boston-based Center for Connected Health, a division of Partners HealthCare. The two will jointly market their services to deliver specialty care from Massachusetts General Hospital and Brigham and Women’s Hospital (BWH) in Boston using IT to help patients access specialty healthcare providers in the Partners network.

According to a statement from the two organizations, the agreement adds a robust tele-specialty component to CHS’ portfolio of employee health services, giving its Fortune 1,000 clients and their workforces broader access to healthcare, beyond services provided in their actual Onsite Health Centers.

For example, with the Center for Connected Health’s telemedicine capabilities CHS will be able to provide its patients with quick and convenient specialist consultations through the Partners Online Specialty Consultations system, a web-based application that enables consumers and their physicians to have “anytime, anywhere” access to the knowledge base of the more than 4,000 specialists located at Mass General and BWH.

The Center for Connected Health has led innovation in several areas, including remote home monitoring and between-visit care with programs in heart failure, hypertension, diabetes, other chronic conditions and technology-enabled access to specialist care.



Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.